Clinical

Dataset Information

0

A phase Ib/II study evaluating Fruquintinib plus 5-Fluorouracil/Leucovorin (5FU/LV) beyond progression on Fruquintinib monotherapy in metastatic colorectal cancer


ABSTRACT: Interventions: experimental group:Fruquintinib plus 5-Fluorouracil /Leucovorin Primary outcome(s): recommended phase 2 dose (RP2D);6-month overall survival rate Study Design: Single arm

DISEASE(S): Metastatic Colorectal Cancer Beyond Progression On Fruquintinib Monotherapy

PROVIDER: 2693103 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2354180 | ecrin-mdr-crc
| S-EPMC6700039 | biostudies-literature
| 2154098 | ecrin-mdr-crc
| 2614860 | ecrin-mdr-crc
| S-EPMC9138435 | biostudies-literature
| 2180115 | ecrin-mdr-crc
| S-EPMC5244709 | biostudies-literature
| PRJEB50527 | ENA
| 2353794 | ecrin-mdr-crc
| S-EPMC4224043 | biostudies-literature